Terns Pharmaceuticals shares owned by Goldman Sachs Group
Quarter-by-quarter ownership of Terns Pharmaceuticals (TERN) shares owned by Goldman Sachs Group
from 13F filings
Historical chart of Goldman Sachs Group investment in Terns Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Terns Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Terns Pharmaceuticals by Goldman Sachs Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $4.8M | 699k | 6.81 |
| 2024-03-31 | $1.4M | 207k | 6.56 |
| 2023-12-31 | $556k | 86k | 6.49 |
| 2023-09-30 | $1.3M | 259k | 5.03 |
| 2023-06-30 | $506k | 58k | 8.75 |
| 2023-03-31 | $1.1M | 89k | 11.84 |
| 2022-12-31 | $110k | 11k | 10.18 |
| 2022-06-30 | $41k | 17k | 2.47 |
| 2022-03-31 | $49k | 16k | 2.98 |
| 2021-12-31 | $108k | 15k | 7.10 |